| Literature DB >> 35046944 |
Wenlong Cai1,2, Surendra Kumar3, Umasuthan Navaneethaiyer3, Albert Caballero-Solares3, Laura A Carvalho1, Shona K Whyte1, Sara L Purcell1, Nellie Gagne4, Tiago S Hori5, Melissa Allen5, Richard G Taylor6, Rachel Balder6, Christopher C Parrish3, Matthew L Rise3, Mark D Fast1.
Abstract
Sea lice (Lepeophtheirus salmonis) are ectoparasitic copepods that cause significant economic loss in marine salmoniculture. In commercial salmon farms, infestation with sea lice can enhance susceptibility to other significant pathogens, such as the highly contagious infectious salmon anemia virus (ISAv). In this study, transcriptomic analysis was used to evaluate the impact of four experimental functional feeds (i.e. 0.3% EPA/DHA+high-ω6, 0.3% EPA/DHA+high-ω6+immunostimulant (IS), 1% EPA/DHA+high-ω6, and 1% EPA/DHA+high-ω3) on Atlantic salmon (Salmo salar) during a single infection with sea lice (L. salmonis) and a co-infection with sea lice and ISAv. The overall objectives were to compare the transcriptomic profiles of skin between lice infection alone with co-infection groups and assess differences in gene expression response among animals with different experimental diets. Atlantic salmon smolts were challenged with L. salmonis following a 28-day feeding trial. Fish were then challenged with ISAv at 18 days post-sea lice infection (dpi), and maintained on individual diets, to establish a co-infection model. Skin tissues sampled at 33 dpi were subjected to RNA-seq analysis. The co-infection's overall survival rates were between 37%-50%, while no mortality was observed in the single infection with lice. With regard to the infection status, 756 and 1303 consensus differentially expressed genes (DEGs) among the four diets were identified in "lice infection vs. pre-infection" and "co-infection vs. pre-infection" groups, respectively, that were shared between the four experimental diets. The co-infection groups (co-infection vs. pre-infection) included up-regulated genes associated with glycolysis, the interferon pathway, complement cascade activity, and heat shock protein family, while the down-regulated genes were related to antigen presentation and processing, T-cell activation, collagen formation, and extracellular matrix. Pathway enrichment analysis conducted between infected groups (lice infection vs. co-infection) resulted in several immune-related significant GO terms and pathways unique to this group, such as "autophagosome", "cytosolic DNA-sensing pathway" and "response to type I interferons". Understanding how experimental functional feeds can impact the host response and the trajectory of co-infections will be an essential step in identifying efficacious intervention strategies that account for the complexities of disease in open cage culture.Entities:
Keywords: Atlantic salmon; co-infection; functional diets; immune response; infectious salmon anemia virus (ISAv); sea lice; transcriptome
Mesh:
Substances:
Year: 2022 PMID: 35046944 PMCID: PMC8763012 DOI: 10.3389/fimmu.2021.787033
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Experimental functional diet composition.
| 0.3% FA(0.3% EPA+DHA High Ω6)a | 0.3% FA+IS(0.3% EPA+DHA High Ω6 Immunostimulant) | 1% FAω6(1% EPA+DHA High Ω6)b | 1% FAω3(1% EPA+DHA High Ω3)c | |
|---|---|---|---|---|
| Fish oil (% diet) | 0.09 | 0.09 | 4.32 | 4.25 |
| Soy oil (% diet) | 12.50 | 12.50 | 10.10 | – |
| Linseed oil (% diet) | – | – | – | 6.45 |
| Poultry fat (% diet) | 2.41 | 2.41 | 0.58 | 4.30 |
| Rapeseed oil (% diet) | – | – | – | – |
| Added oil (% diet) | 15.00 | 15.00 | 15.00 | 15.00 |
| EPA+DHA (% diet) | 0.34 | 0.34 | 1.00 | 1.00 |
| Saturated (% total FA) | 17.0 | 17.0 | 17.0 | 17.0 |
| 18:2n-6 (% total FA) | 48.1 | 48.1 | 38.1 | 12.3 |
| 18:3n-3 (% total FA) | 7.2 | 7.2 | 5.9 | 24.6 |
| n-6 (% total FA) | 0.3% EPA+DHA | 0.3% EPA+DHA | 1% EPA+DHA | 1% EPA+DHA |
| n-3 (% total FA) | High Ω6 | High Ω6 | High Ω6 | High Ω3 |
athis diet was the same diet indicated as 0.3% FA↑ω6 in Katan et al, 2020. bthis diet was the same diet indicated as 1% FA↑ω6 in Katan et al, 2020. cthis diet was the same diet indicated as 1% FA↑ω3 in Katan et al, 2020.
Figure 1Diagram of the experimental design. Experimental diets were administered for 28 days prior to infection. Day 0 was the day of lice infection, then ISAv was introduced by co-habitation on day 18. Pre-infection skin samples sample A were collected at 3 days prior to lice infection. Skin sample from lice attachment site from single infection sample B or co-infection sample C were collected at 33 days post-infection.
Average lice counts and viral load (mean ± SD) of fish exposed to a single (lice) and co-infection (lice-then-ISAv) and cumulative survival rate for co-infection.
| Name | Diet | Average lice counts | Virus load(Ct) | Cumulative survival rate (%) | ||
|---|---|---|---|---|---|---|
| Pre-Infection | Single Infection(33dpi) | Co-Infection(33 dpi) | Co-Infection(33 dpi) | |||
| 0.3% FA | 0.3% EPA/DHA+high-ω6 | 0 ± 0 | 12.9 ± 0.8 | 11.7 ± 0.9 | 32.9 ± 1.5 | 47.8 |
| 0.3% FA+IS | 0.3% EPA/DHA+high-ω6 | 0 ± 0 | 11.2 ± 0.7 | 14.1 ± 1.0 | 33.3 ± 0.9 | 50.0 |
| 1% FAω6 | 1% EPA/DHA+high-ω6 | 0 ± 0 | 12.0 ± 1.0 | 13.6 ± 1.1 | 32.2 ± 0.2 | 46.7 |
| 1% FAω3 | 1% EPA/DHA+high-ω3 | 0 ± 0 | 10.4 ± 0.8 | 16.1 ± 0.9 | 31.8 ± 0.7 | 37.3 |
Comparison of differentially expressed genes (DEGs) within each diet group.
| Diet | Treatment Comparison | Number of DEGs | ||
|---|---|---|---|---|
| Up-Regulation | Down-Regulation | Total | ||
| 0.3% FA | Single infection vs Control | 955 | 1289 | 2244 |
| Co-infection vs Control | 1638 | 1169 | 2807 | |
| Co-infection vs Single infection | 1016 | 292 | 1308 | |
| 0.3% FA+IS | Single infection vs Control | 976 | 1191 | 2167 |
| Co-infection vs Control | 1482 | 2189 | 3671 | |
| Co-infection vs Single infection | 276 | 288 | 564 | |
| 1.0% FAω6 | Single infection vs Control | 589 | 1151 | 1740 |
| Co-infection vs Control | 1662 | 1716 | 3378 | |
| Co-infection vs Single infection | 865 | 116 | 981 | |
| 1.0% FAω3 | Single infection vs Control | 1221 | 1611 | 2832 |
| Co-infection vs Control | 1567 | 1437 | 3004 | |
| Co-infection vs Single infection | 1042 | 383 | 1425 | |
False discovery rate (FDR)<5%.
Comparison of differentially expressed genes (DEGs) among the diet groups.
| Treatment | Diet Comparison | Number of DEGs | ||
|---|---|---|---|---|
| Up-Regulation | Down-Regulation | Total | ||
| pre-infection | 0.3% FA+IS vs. 0.3% FA | 217 | 158 | 375 |
| 1% FAω6 vs. 0.3% FA | 79 | 68 | 147 | |
| 1% FAω3 vs. 0.3% FA | 27 | 69 | 96 | |
| 1% FAω6 vs. 1% FAω3 | 77 | 28 | 105 | |
| 0.3% FA+IS vs. 1% FAω3 | 110 | 68 | 178 | |
| 1% FAω6 vs.0.3% FA+IS | 146 | 157 | 303 | |
| single infection | 0.3% FA+IS vs. 0.3% FA | 445 | 37 | 482 |
| 1% FAω6 vs. 0.3% FA | 70 | 40 | 110 | |
| 1% FAω3 vs. 0.3% FA | 52 | 71 | 123 | |
| 1% FAω6 vs. 1% FAω3 | 103 | 48 | 151 | |
| 0.3% FA+IS vs. 1% FAω3 | 725 | 233 | 958 | |
| 0.3% FA+IS vs.1% FAω6 | 537 | 27 | 564 | |
| co-infection | 0.3% FA+IS vs. 0.3% FA | 63 | 244 | 307 |
| 1% FAω6 vs. 0.3% FA | 220 | 351 | 571 | |
| 1% FAω3 vs. 0.3% FA | 139 | 238 | 377 | |
| 1% FAω6 vs. 1% FAω3 | 204 | 113 | 317 | |
| 0.3% FA+IS vs. 1% FAω3 | 104 | 149 | 253 | |
| 1% FAω6 vs. 0.3% FA+IS | 116 | 55 | 171 | |
False discovery rate (FDR)<5%.
Figure 2Overview of the global transcript expression profiles. (A) Venn diagram showing the distribution of DEGs identified between single infection and pre-infection among the four different diets. (B) Venn diagram showing the distribution of DEGs identified between co-infection and pre-infection among the four different diets. (C) Venn diagram showing the distribution of DEGs identified between co-infection and single among the four different diets. (D) Multidimensional scaling (MDS) analysis of the expression data similarity among the 12 groups.
Figure 3The ClueGO based enriched gene ontology (GO) terms and pathway identified from genes differently experessed in four experimental diets (A) 0.3% FA+IS, (B) 1% FAω3, (C) 1% FAω6, and (D) 0.3% FA of pre-infected group of samples. The shape size shows the GO terms and pathway significance (larger shape (e.g. circle, square) = higher significance). The shape depicts database source i.e., GO biological process (circle), GO cellular component (hexagon), GO molecular function (parallelogram), and KEGG pathways (square). The statistics of representative GO terms or pathways are tabulated in .
Figure 4Gene Ontology (GO) pathway enrichment analysis of the shared genes among the four diets between single infection and control (pre-infection). (A) Enriched pathways among up-regulated genes. (B) Enriched pathways among down-regulated genes.
Selected list of differentially expressed genes (DEGs) during L. salmonis and ISAv co-infection in the skin of Atlantic salmon, when compared with the pre-infected control.
| Category | Gene ID | Gene symbol | Gene description | Fold-changes (log2FC) | |||
|---|---|---|---|---|---|---|---|
| 0.3% FA | 0.3% FA+ IS | 1% FAω6 | 1% FAω3 | ||||
| Muscle structure development |
|
| Fibroblast growth factor 12 | 3.31 | 3.54 | 4.02 | 3.70 |
| LOC106589658 |
| Actin, alpha skeletal muscle 2 | 6.01 | 6.00 | 7.34 | 9.33 | |
| LOC106575818 |
| Myosin light chain 3 | 6.91 | 6.88 | 8.23 | 8.66 | |
| LOC106609638 |
| Troponin I | 9.26 | 7.25 | 9.06 | 7.09 | |
| Interferon pathway | LOC106583433 |
| Interferon-induced protein 44 | 5.62 | 4.14 | 3.69 | 3.74 |
| LOC106608578 |
| Interferon-induced protein with tetratricopeptide repeat 5 | 5.80 | 3.15 | 5.80 | 5.57 | |
| LOC106578964 |
| Interferon-induced protein with tetratricopeptide repeat 5 | 2.96 | 2.03 | 2.93 | 3.10 | |
| LOC106566099 |
| Radical S-adenosyl methionine domain-containing protein 2 | 5.81 | 4.30 | 6.03 | 6.26 | |
| Complement system |
|
| Complement C6 | 4.52 | 4.81 | 3.28 | 4.36 |
| LOC106612870 |
| Complement C4 | 4.04 | 4.63 | 6.08 | 5.53 | |
| LOC106572353 |
| Complement factor H | 2.12 | 2.29 | 2.41 | 2.04 | |
| LOC106565874 |
| Complement decay-accelerating factor | 1.94 | 3.43 | 1.97 | 1.95 | |
|
|
| Mannose-binding protein C | 3.60 | 4.54 | 3.84 | 4.35 | |
| Heat shock proteins |
|
| Heat shock protein beta-7 | 7.27 | 8.27 | 5.07 | 6.61 |
|
|
| Heat shock protein 70 | 5.01 | 4.34 | 5.37 | 6.51 | |
| LOC106603948 |
| Heat shock protein beta-1 | 4.64 | 3.30 | 5.69 | 3.18 | |
| LOC106579825 |
| Heat shock protein beta-8 | 3.58 | 4.33 | 4.96 | 3.71 | |
|
|
| Heat shock protein beta-8 | 1.90 | 2.13 | 2.31 | 1.73 | |
| Iron homeostatis | LOC106599278 |
| Ferritin, middle subunit | -3.07 | -1.94 | -2.20 | -1.84 |
| LOC106600764 |
| Ferritin, middle subunit | -3.64 | -1.59 | -2.29 | -2.39 | |
| Chemokine signaling | LOC106600142 |
| C-C motif chemokine 20 | -2.89 | -4.23 | -2.47 | -3.09 |
|
|
| C-C chemokine receptor type 6 | -2.17 | -2.93 | -2.49 | -2.16 | |
| LOC106600446 |
| C-C motif chemokine 4 | -2.14 | -2.87 | -2.19 | -1.95 | |
| LOC106590189 |
| C-C chemokine receptor type 9 | -1.66 | -2.92 | -2.60 | -3.10 | |
| Antigen presentation | LOC106564360 |
| H-2 class II histocompatibility antigen, A-Q alpha | -2.17 | -2.28 | -2.67 | -1.92 |
| LOC106600246 |
| H-2 class II histocompatibility antigen, I-E beta | -1.76 | -3.26 | -2.42 | -2.04 | |
| b2m |
| beta-2-microglobulin | -1.14 | -1.82 | -1.02 | NS | |
| LOC106562659 |
| Major histocompatibility complex class I-related gene protein | -1.69 | -1.51 | -1.78 | -1.50 | |
| LOC106564356 |
| rano class II histocompatibility antigen, A beta chain | -1.78 | -1.66 | -2.03 | -1.91 | |
| LOC106565699 |
| H-2 class II histocompatibility antigen, A-U alpha chain | -1.48 | -2.95 | -2.31 | -1.64 | |
| T-cell development | LOC106586939 |
| T-cell specific surface glycoprotein CD28 | -2.14 | -2.18 | -1.83 | -3.51 |
| LOC106602649 |
| T-cell surface glycoprotein CD5 | -1.73 | -3.08 | -2.27 | -2.59 | |
|
|
| T-cell activation Rho GTPase-activating protein | -1.52 | -2.55 | -2.10 | -1.92 | |
| LOC106563917 |
| T-cell surface protein tactile | -1.42 | -2.07 | -2.12 | -1.84 | |
| LOC106611417 |
| T-cell receptor beta-2 chain C region | -1.36 | -2.24 | -1.85 | -1.88 | |
| Collagen synthesis |
|
| Collagen alpha-1(XI) chain | -2.65 | -4.68 | -4.18 | -4.20 |
| LOC106583145 |
| Collagen alpha-1(XII) chain | -2.15 | -2.30 | -2.26 | -3.11 | |
| LOC106593482 |
| Collagen alpha-1(XI) chain | -2.08 | -2.96 | -2.84 | -3.07 | |
| LOC106588396 |
| Collagen alpha-2(XI) chain | -1.72 | -4.13 | -2.89 | -2.79 | |
| LOC106607727 |
| Collagen alpha-1(X) chain | -1.66 | -3.81 | -3.44 | -3.02 | |
| LOC106584045 |
| Collagen alpha-1(XXIV) chain | -2.14 | -3.59 | -2.73 | -3.18 | |
| Tissue repair | LOC100286414 |
| Fibromodulin | -4.01 | -5.28 | -5.18 | -4.44 |
| LOC106590496 |
| Proteoglycan 4 | -5.71 | -5.90 | -4.04 | -5.12 | |
| LOC101448046 |
| Serine protease-like protein | 2.40 | NS | 1.98 | 2.02 | |
| LOC106562051 |
| Matrix metalloproteinase 15 | -2.84 | -2.88 | -2.35 | -3.13 | |
| LOC106569443 |
| Matrix metalloproteinase 14 | 1.36 | 1.48 | 1.37 | 1.98 | |
| fgfp12 |
| Fibroblast growth factor 12 | 3.31 | 3.54 | 4.03 | 3.71 | |
| fgfp1 |
| Fibroblast growth factor-binding protein 1 | 2.55 | 3.89 | 3.71 | 3.36 | |
NS, not significant; IS, indicates immunostimulant.
Figure 5Hierarchical clustering of shared differentially expressed genes (DEGs) identified in three groups (single vs. pre-infection, co-infection vs. pre-infection, and co-infection vs. single infection). The normalized expression value (FPKM) for each samples (columns) and genes (rows) are illustrated in red (up-regulated) and blue (down-regulated) color in the heatmap.
Figure 6The ClueGO based enriched gene ontology (GO) terms and pathways identified from genes differently expressed in three group comparison. (A) single (lice) infection vs. pre-infection, (B) co-infection (lice+ISAv) vs. pre-infection, and (C) co-infection (lice+ISAv) vs. single infection. The shape size shows the GO terms and pathway significance (bigger he size higher the significance). The shape depicts batabase source i.e., GO biological process (ellipse), GO cellular component (hexagon), GO molecular function (parallelogram), and KEGG pathways (square). The statistics of representative GO terms or pathway are tabulated in .
Figure 7qPCR validation of the selected genes for RNA-seq data. (A) Scatterplot of log2-transformed gene expression fold-changes between treatment groups calculated from RNA-seq data and qPCR assay. (B–J) Boxplots of qPCR data for the selected genes of interest. Plots reveal median calibrated normalized relative quantities (CNRQs) values and interquartile ranges in log2 scale. On x-axis: letter A indicates the group receiving the 0.3% FA diet; letter B indicates the group receiving the 0.3% FA+IS diet; letter C indicates the group receiving 1% FAω6 diet; letter D indicates the group receiving the 1% FAω3 diet. Statistics was conducted within each diet. Different letters indicate significant difference (p<0.05).